Genentech: Baris Bingol

I am proud to be part of the scientific team at Genentech that values scientific excellence above all to fuel therapeutic programs for patients in need.

Baris BINGOL, Genentech, California, Department of Neuroscience

Multiclass semantic segmentation mediated neuropathological readout in Parkinson's disease - ScienceDirect

Baris BINGOL, Genentech, California, Department of Neuroscience

PPEF2 Opposes PINK1-Mediated Mitochondrial Quality Control by Dephosphorylating Ubiquitin - ScienceDirect

Genentech: Baris Bingol

Genentech: Casper Hoogenraad VP Neuroscience, Neuroscience

From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors

Global and Regional Changes in Perivascular Space in Idiopathic and Familial Parkinson's Disease - Donahue - 2021 - Movement Disorders - Wiley Online Library

The mitochondrial deubiquitinase USP30 opposes parkin--ediated mitophagy - Document - Gale OneFile: Health and Medicine

Gail D Lewis - Senior Principal Scientist - Genentech

Bay Area Molecular Neuroscience Meeting – July 20th, 2018 – UC Berkeley

Genentech: Eric Brown Vice President, Translational Biology

Ocular phenotypes in a mouse model of impaired glucocerebrosidase activity